Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Healthcare Drug Manufacturers - Specialty & Generic
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary drug delivery platforms, which include Multiplexed Molecular Penetration Enhancers and DuraPee that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company’s prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures. Its non-prescription portfolio offers dermocosmetic products, such as face creams, cleansers, exfoliants, masks, serums, and suncare to treat mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea under the Laboratoire Dr Renaud and Aquafolia brands; and m...


TSX:CTX - Post by User

Crescita Therapeutics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1776)
•••
  • Possibleidiot01X
Post by Possibleidiot01on Mar 16, 2026 10:20am
72 Views
Post# 36934242

Mathieu Martin comment on offer

Mathieu Martin comment on offer
Crescita Therapeutics (TSX: CTX) Announces Definitive Agreement to Be Acquired by ClinActiv Holdings

The $0.80/share all-cash offer represents a 72% premium to the last closing price!

While the offer from a strategic buyer comes with a nice short-term premium, this must be disappointing for long-term shareholders. The stock has been going sideways, stuck in a $0.35 to $1.00 range, for the better part of 10 years.

https://lnkd.in/eupSKWVd


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities